Ulla Hedner (Former)

41 – 50 of 57

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/326f8035-6f82-4ffc-9b65-000afeb8e414?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2001
Mark Anti- and procoagulant activities in factor VII-deficient subjects
Astermark, Jan ^LU ; Tengborn, L ; Hedner, Ulla ^LU and Berntorp, Erik ^LU (2001) In Thrombosis Research 101(6). p.435-440
- Contribution to journal › Article
2000
Mark Correlation between different intensities of anti-vitamin K treatment and coagulation parameters
Jerkeman, Anna ^LU ; Astermark, Jan ^LU ; Hedner, Ulla ^LU ; Lethagen, Stefan ^LU ; Olsson, Carl-Gustav and Berntorp, Erik ^LU (2000) In Thrombosis Research 98(6). p.467-471
- Contribution to journal › Article
1998
Mark Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model
Holst, J. ^LU ; Kristensen, A. T. ; Kristensen, H. I. ; Ezban, M. and Hedner, U. ^LU (1998) In European Journal of Vascular and Endovascular Surgery 15(6). p.515-520
- Contribution to journal › Article
1996
Mark Experimental haemorrhagic effect of two-domain non-glycosylated tissue factor pathway inhibitor compared to low molecular weight heparin
Holst, Jan ^LU ; Lindblad, Bengt ^LU ; Matthíasson, Stefan E. ; Stjernquist, Ulf ; Ezban, Mirella ; Østergaard, Per B. and Hedner, Ulla ^LU (1996) In Thrombosis and Haemostasis 75(4). p.585-589
- Contribution to journal › Article
Mark Pharmacokinetics and delayed experimental anti-thrombotic effect of two domain non-glycosylated tissue factor pathway inhibitor
Holst, Jan ^LU ; Lindblad, Bengt ^LU ; Westerlund, Gertie ; Bregengaard, Claus ; Ezban, Mirella ; ØStergaard, Per B. ; Nordfang, Ole and Hedner, Ulla ^LU (1996) In Thrombosis Research 81(4). p.461-470
- Contribution to journal › Article
Mark Does glycosylation influence the experimental antithrombotic effect of a two-domain tissue factor pathway inhibitor?
Holst, Jan ^LU ; Lindblad, Beugt ^LU ; Nordfang, Oie ; Østergaard, Per B. and Hedner, Ulla ^LU (1996) In Pathophysiology of Haemostasis and Thrombosis 26(1). p.23-30
- Contribution to journal › Article
1994
Mark Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin(TM)). An experimental investigation in healthy volunteers
Holst, J. ^LU ; Lindblad, B. ^LU ; Bergqvist, D. ; Garre, K. ; Nielsen, H. ; Hedner, U. ^LU and Ostergaard, P. B. (1994) In Blood Coagulation and Fibrinolysis 5(5). p.795-803
- Contribution to journal › Article
Mark Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI_1-161) in experimental venous thrombosis : A comparison with low molecular weight heparin
Holst, J. ^LU ; Lindblad, B. ^LU ; Bergqvist, D. ; Nordfang, O. ; Ostergaard, P. B. ; Petersen, J. G.L. ; Nielsen, G. and Hedner, U. ^LU (1994) In Thrombosis and Haemostasis 71(2). p.214-219
- Contribution to journal › Article
1993
Mark Tissue factor pathway inhibitor (TFPI) and its response to heparin in patients with spontaneous deep vein thrombosis
Holst, Jan ^LU ; Lindblad, Bengt ^LU ; Wedeberg, Eva ; Bergqvist, David ; Nordfang, Ole ; Østergaard, Per B. and Hedner, Ulla ^LU (1993) In Thrombosis Research 72(5). p.467-470
- Contribution to journal › Article
1990
Mark Low molecular weight heparin compared with dextran as prophylaxis against thrombosis after total hip replacement
Mätzsch, Thomas ^LU ; Bergqvist, D ; Fredin, H and Hedner, Ulla ^LU (1990) In Acta Chirurgica Scandinavica 156(6-7). p.445-450
- Contribution to journal › Article